Biotech-powered, plant-based seafood poised to cut overfishing, pollution and ‘food fraud’

dsc
Credit: Wild Type Inc.

Plant-based seafood specialist Kuleana is targeting seafood and sushi lovers with what it describes as the ‘next generation of raw tuna powered by plants and biotechnology’. FoodNavigator speaks to co-founder and CEO Jacek Prus about developing plant-based seafoods without the ‘environmental and ethical consequences’.

Germany-based Kuleana is a food tech start-up with big ambitions. It wants to help solve some of the most pressing problems in the tuna supply chain. This is a broad-ranging set of concerns ranging from under-supply and pollution, to health and food fraud, according to the company’s founder and chief executive Jacek Prus.

The company knew that texture would be the ‘most difficult’ organoleptic trait to mimic – so this was the ‘first focus’.

“We began by exploring multiple avenues from working with partners in extrusion and other texturizing technologies to working on different plant-based formulations. Ultimately, we discovered the power of combining algae and plant proteins using traditional processes in an unconventional way,”​ Prus detailed.

“In another arm of the company we are developing novel biotechnology processes that will be implemented into our products for further texture and flavor enhancement.

Read the original post

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-09-10-at-11.50.46-AM
Did COVID vaccines kill 2,500 service members? RFK Jr. hires an investigator who compares vaccine promoters to Nazi doctors
ChatGPT-Image-Sep-13-2026-10_24_17-AM
Bayer urges court to approve $7.25 billion Monsanto Roundup settlement that could limit its future liabilities
ChatGPT-Image-Sep-15-2026-06_05_13-PM
CRISPR fine-tuning unlocks vitamin C-rich potatoes without yield loss
Screenshot-2026-09-10-at-12.20.19-PM
'Jet fuel didn't melt the steel': 9/11 conspiracy theories debunked
ChatGPT-Image-Sep-15-2026-05_59_18-PM
RFK Jr. spent two years distancing himself from Children’s Health Defense. Now he’s keynoting its anti-vaccine DC conference.
Screenshot-2026-09-11-at-2.26.23-PM
Newly approved GMO chestnut trees planted across from the White House are stirring debate
ChatGPT-Image-Aug-28-2026-03_33_46-PM
Viewpoint: Bad science—Five bogus Trump administration claims about vaccines and autism
Screenshot 2026-09-10 at 11.28
A meaty problem: How to make cell-grown protein taste like steak, chicken, and seafood
ChatGPT-Image-Sep-2-2026-10_30_14-PM
Zero: That is the official American measles death toll for 2026. Here is what RFK Jr.’s CDC leaves out.
Screenshot-2026-09-14-at-10.52.30-AM
AI is being used in dangerous bioscience experiments
Screenshot-2026-09-15-at-11.04.54-AM
Viewpoint: Childhood deaths in dispute: Why the CDC vs Pennsylvania conflict over measles vaccines matters
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.